Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents

Journal of the American Academy of Dermatology

Volumn 62, Issue 3, 2010, Pages 411-414

  Piraccini, Bianca Maria ^a   Sisti, Andrea ^a   Tosti, Antonella ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

amorolfine nail lacquer; dermatophytes; itraconazole; systemic antifungal; terbinafine; toenail onychomycosis

Indexed keywords

AMOROLFINE; ITRACONAZOLE; LOCETAR; TERBINAFINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENETIC PREDISPOSITION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; SHOE; TOENAIL ONYCHOMYCOSIS; TREATMENT DURATION; TRICHOPHYTON; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM;

ADULT; AGED; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; FEMALE; FOOT DERMATOSES; HUMANS; ITRACONAZOLE; LACQUER; MALE; MIDDLE AGED; MORPHOLINES; NAILS; NAPHTHALENES; ONYCHOMYCOSIS; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 76249111790     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.04.062     Document Type: Article

References (10)

1. Sigurgeirsson B., Olafsson J.H., Steinsson J.B., Paul C., Billstein S., and Evans E.G. Long-term effectiveness of treatment with terbinafine vs itraconazole in onychomycosis: a 5-year blinded prospective follow-up study. Arch Dermatol 138 (2002) 353-357
2. Scher R.K., and Baran R. Onychomycosis in clinical practice: factors contributing to recurrence. Br J Dermatol 149 Suppl (2003) 5-9
3. Tosti A., Hay R., and Arenas-Guzman R. Patients at risk of onychomycosis-risk factor identification and active prevention. J Eur Acad Dermatol Venereol 19 Suppl (2005) 13-16
4. Sigurgeirsson B., and Steingrimsson O. Risk factors associated with onychomycosis. J Eur Acad Dermatol Venereol 18 (2004) 48-51
5. Gupta A.K., Gupta M.A., Summerbell R.C., Cooper E.A., Konnikov N., and Albreski D. The epidemiology of onychomycosis: possible roles of smoking and peripheral arterial disease. J Eur Acad Dermatol Venereol 1 (2000) 466-469
6. Pierard G.E., and Pierard-Franchimont C. The nail under fungal siege in patients with type II diabetes mellitus. Mycoses 48 (2005) 339-342
7. Tosti A., Piraccini B.M., Stinchi C., and Colombo M.D. Relapses of onychomycosis after successful treatment with systemic antifungals: a three-year follow-up. Dermatology 197 (1998) 162-166
8. Zaias N., Tosti A., Rebell G., Morelli R., Bardazzi F., Bieley H., et al. Autosomal dominant pattern of distal subungual onychomycosis caused by Trichophyton rubrum. J Am Acad Dermatol 34 (1996) 302-304
9. Zaias N., and Rebell G. Chronic dermatophytosis caused by Trichophyton rubrum. J Am Acad Dermatol 35 Suppl (1996) S17-S20
10. Rebell G., and Zaias N. Introducing the syndromes of human dermatophytosis. Cutis 67 (2001) 6-17